Integrated Pulmonary Index in Gastroscopic Procedures
The Effects of Ketamine and Propofol and Remifentanil and Propofol Combinations on Integrated Pulmonary Index During Sedation in Gastroscopy
1 other identifier
observational
60
1 country
1
Brief Summary
Various complications are the leading cause of morbidity in sedation practices in endoscopic procedures, and guidelines recommend continuous monitoring of circulation, respiratory function, and ventilation. Integrated Pulmonary Index (IPI), one of the methods that can be used in this monitoring, gives a single numerical value obtained by continuous and simultaneous joint mathematical analysis of Oxygen saturation, End-tidal carbon dioxide concentration, respiratory rate, and heart rate values and is a good monitorization in these interventions. and provides tracking. In this study, the aim is to determine the role of IPI in the diagnosis and follow-up of respiratory complications in patients who were sedated during gastroscopy procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 6, 2023
CompletedFirst Submitted
Initial submission to the registry
March 31, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2023
CompletedAugust 22, 2023
August 1, 2023
8 months
March 31, 2023
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
respiratory complications comparing different sedative groups
Comparison of sedation safety and efficacy of Ketamine and Propofol and Remifentanil and Propofol administration to be applied to patients in endoscopy by using integrated pulmonary index (1-10)
Measurements will be in 4 time frames; before induction anesthesia, 5 minutes after the induction of sedation, 10 minutes after the induction, 5 minutes after the end of the procedure
Study Arms (2)
ketaprop
At the beginning of anesthesia, 0.25 mg/kg ketamine and 0.75 mg/kg propofol will be administered.
remiprop
At the beginning of anesthesia, 1 mcg/kg of remifentanil and 0.75 mg/kg propofol will be administered.
Interventions
Eligibility Criteria
over the age of 18 who will undergo endoscopic intervention
You may qualify if:
- ASA 1-2-3 risk scored patients,
- patients over the age of 18 who will undergo endoscopic intervention
You may not qualify if:
- Patients who need mechanical ventilator support,
- patients who need emergency endoscopic intervention,
- patients with a history of substance abuse,
- patients with a history of allergy to the drugs to be used,
- pregnant women will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpaşa TREH
Istanbul, Gaziosmanpaşa, 34255, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
zuhal çavuş, MD
gaziosmanpasa TREH
- STUDY DIRECTOR
döndü genç moralar, MD
gaziosmanpasa TREH
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor, principal investigator
Study Record Dates
First Submitted
March 31, 2023
First Posted
April 25, 2023
Study Start
February 6, 2023
Primary Completion
September 30, 2023
Study Completion
November 5, 2023
Last Updated
August 22, 2023
Record last verified: 2023-08